Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression

Toxicology and Applied Pharmacology

Volumn 272, Issue 1, 2013, Pages 108-116

  Wang, Lei ^a   Kuang, Lisha ^a   Hitron, John Andrew ^a   Son, Young Ok ^a   Wang, Xin ^a   Budhraja, Amit ^a   Lee, Jeong Chae ^a,b   Pratheeshkumar, Poyil ^a   Chen, Gang ^a   Zhang, Zhuo ^a   Luo, Jia ^a   Shi, Xianglin ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Chonbuk National University   (South Korea)

Author keywords

Apigenin; CXCL12; CXCR4; Metastasis; Transformed cell

Indexed keywords

APIGENIN; ARSENIC; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; CELL VIABILITY; COLON CANCER; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING; WOUND HEALING;

APIGENIN; CXCL12; CXCR4; METASTASIS; TRANSFORMED CELL;

APIGENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NF-KAPPA B; PLASMIDS; RECEPTORS, CXCR4; TRANSFECTION; WOUND HEALING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84882770528     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.028     Document Type: Article

References (51)

1. Akashi T., Koizumi K., Tsuneyama K., Saiki I., Takano Y., Fuse H. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci. 2008, 99:539-542.
2. Archibald K.M., Kulbe H., Kwong J., Chakravarty P., Temple J., Chaplin T., Flak M.B., McNeish I.A., Deen S., Brenton J.D., Young B.D., Balkwill F. Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium. Oncogene 2012, 31:4987-4995.
3. Bachelder R.E., Wendt M.A., Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002, 62:7203-7206.
4. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 2004, 14:171-179.
5. Bhandari D., Trejo J., Benovic J.L., Marchese A. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J. Biol. Chem. 2007, 282:36971-36979.
6. Budhraja A., Gao N., Zhang Z., Son Y.O., Cheng S., Wang X., Ding S., Hitron A., Chen G., Luo J., Shi X. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther. 2012, 11:132-142.
7. Chang Q., Pan J., Wang X., Zhang Z., Chen F., Shi X. Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cells. Cancer Res. 2010, 70:5127-5135.
8. Choi E.J., Kim G.H. Apigenin induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 cells. J. Clin. Biochem. Nutr. 2009, 44:260-265.
9. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
10. Escudero-Lourdes C., Wu T., Camarillo J.M., Gandolfi A.J. Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells. Toxicol. Appl. Pharmacol. 2012, 258:10-18.
11. Fernandis A.Z., Prasad A., Band H., Klosel R., Ganju R.K. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004, 23:157-167.
12. Gupta P.B., Mani S., Yang J., Hartwell K., Weinberg R.A. The evolving portrait of cancer metastasis. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:291-297.
13. Haque R., Mazumder D.N., Samanta S., Ghosh N., Kalman D., Smith M.M., Mitra S., Santra A., Lahiri S., Das S., De B.K., Smith A.H. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 2003, 14:174-182.
14. Helbig G., Christopherson K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 2003, 278:21631-21638.
15. Hernandez P.A., Gorlin R.J., Lukens J.N., Taniuchi S., Bohinjec J., Francois F., Klotman M.E., Diaz G.A. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 2003, 34:70-74.
16. Holm N.T., Byrnes K., Li B.D., Turnage R.H., Abreo F., Mathis J.M., Chu Q.D. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence. J. Surg. Res. 2007, 141:53-59.
17. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 2002, 133:1-16.
18. Hurwitz A.A., Foster B.A., Allison J.P., Greenberg N.M., Kwon E.D. The TRAMP mouse as a model for prostate cancer. Curr. Protoc. Immunol. 2001, 25. (Chapter 20, Unit 20).
19. IARC Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 84:269-477.
20. Kang O.H., Lee J.H., Kwon D.Y. Apigenin inhibits release of inflammatory mediators by blocking the NF-kappaB activation pathways in the HMC-1 cells. Immunopharmacol. Immunotoxicol. 2012, 33:473-479.
21. Kim J., Mori T., Chen S.L., Amersi F.F., Martinez S.R., Kuo C., Turner R.R., Ye X., Bilchik A.J., Morton D.L., Hoon D.S. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann. Surg. 2006, 244:113-120.
22. Kitchin K.T., Conolly R. Arsenic-induced carcinogenesis-oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem. Res. Toxicol. 2010, 23:327-335.
23. Kruizinga R.C., Bestebroer J., Berghuis P., de Haas C.J., Links T.P., de Vries E.G., Walenkamp A.M. Role of chemokines and their receptors in cancer. Curr. Pharm. Des. 2009, 15:3396-3416.
24. Kuang L., Wang L., Wang Q., Zhao Q., Du B., Li D., Luo J., Liu M., Hou A., Qian M. Cudratricusxanthone G inhibits human colorectal carcinoma cell invasion by MMP-2 down-regulation through suppressing activator protein-1 activity. Biochem. Pharmacol. 2011, 81:1192-1200.
25. Kulbe H., Hagemann T., Szlosarek P.W., Balkwill F.R., Wilson J.L. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 2005, 65:10355-10362.
26. Leivonen S.K., Kahari V.M. Transforming growth factor-beta signaling in cancer invasion and metastasis. Int. J. Cancer 2007, 121:2119-2124.
27. Li Z.D., Liu L.Z., Shi X., Fang J., Jiang B.H. Benzo[a]pyrene-3,6-dione inhibited VEGF expression through inducing HIF-1alpha degradation. Biochem. Biophys. Res. Commun. 2007, 357:517-523.
28. Libura J., Drukala J., Majka M., Tomescu O., Navenot J.M., Kucia M., Marquez L., Peiper S.C., Barr F.G., Janowska-Wieczorek A., Ratajczak M.Z. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 2002, 100:2597-2606.
29. Marchesi F., Monti P., Leone B.E., Zerbi A., Vecchi A., Piemonti L., Mantovani A., Allavena P. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res. 2004, 64:8420-8427.
30. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
31. Nagasawa T., Nakajima T., Tachibana K., Iizasa H., Bleul C.C., Yoshie O., Matsushima K., Yoshida N., Springer T.A., Kishimoto T. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14726-14729.
32. Pan J.J., Chang Q.S., Wang X., Son Y.O., Liu J., Zhang Z., Bi Y.Y., Shi X. Activation of Akt/GSK3beta and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells. Int. J. Oncol. 2011, 39:1285-1294.
33. Pandey P.K., Yadav S., Pandey M. Human arsenic poisoning issues in central-east Indian locations: biomarkers and biochemical monitoring. Int. J. Environ. Res. Public Health 2007, 4:15-22.
34. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int. J. Oncol. 2007, 30:233-245.
35. Qu W., Tokar E.J., Kim A.J., Bell M.W., Waalkes M.P. Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells. Environ. Health Perspect. 2012, 120:1265-1271.
36. Raman D., Baugher P.J., Thu Y.M., Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007, 256:137-165.
37. Richard C.L., Blay J. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner. Int. J. Oncol. 2007, 30:1215-1222.
38. Schioppa T., Uranchimeg B., Saccani A., Biswas S.K., Doni A., Rapisarda A., Bernasconi S., Saccani S., Nebuloni M., Vago L., Mantovani A., Melillo G., Sica A. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 2003, 198:1391-1402.
39. Shukla S., Mishra A., Fu P., MacLennan G.T., Resnick M.I., Gupta S. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB J. 2005, 19:2042-2044.
40. Smith M.C., Luker K.E., Garbow J.R., Prior J.L., Jackson E., Piwnica-Worms D., Luker G.D. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004, 64:8604-8612.
41. Son Y.O., Wang L., Poyil P., Budhraja A., Hitron J.A., Zhang Z., Lee J.C., Shi X. Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3beta/beta-catenin signaling. Toxicol. Appl. Pharmacol. 2012, 264:153-1600.
42. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003, 425:307-311.
43. Su H., Sobrino Najul E.J., Toth T.A., Ng C.M., Lelievre S.A., Fred M., Tang C.K. Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis. Cancer Lett. 2011, 307:132-140.
44. Sung B., Jhurani S., Ahn K.S., Mastuo Y., Yi T., Guha S., Liu M., Aggarwal B.B. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res. 2008, 68(21):8938-8944.
45. Uchida D., Begum N.M., Almofti A., Nakashiro K., Kawamata H., Tateishi Y., Hamakawa H., Yoshida H., Sato M. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp. Cell Res. 2003, 290:289-302.
46. Ujiki M.B., Ding X.Z., Salabat M.R., Bentrem D.J., Golkar L., Milam B., Talamonti M.S., Bell R.H., Iwamura T., Adrian T.E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol. Cancer 2006, 5:76.
47. Wang L., Kuang L., Pan X., Liu J., Wang Q., Du B., Li D., Luo J., Liu M., Hou A., Qian M. Isoalvaxanthone inhibits colon cancer cell proliferation, migration and invasion through inactivating Rac1 and AP-1. Int. J. Cancer 2010, 127:1220-1229.
48. Wang X., Son Y.O., Chang Q., Sun L., Hitron J.A., Budhraja A., Zhang Z., Ke Z., Chen F., Luo J., Shi X. NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium. Toxicol. Sci. 2011, 123:399-410.
49. Way T.D., Kao M.C., Lin J.K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 2004, 279:4479-4489.
50. Xia J., Chen N., Hong Y., Chen X., Tao X., Cheng B., Huang Y. Expressions of CXCL12/CXCR4 in oral premalignant and malignant lesions. Mediat. Inflamm. 2012, 2012:516395.
51. Zheng P.W., Chiang L.C., Lin C.C. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 2005, 76:1367-1379.